AaslidRNewellDWStossRSortebergWLindegaardKF. Assessment of cerebral autoregulation dynamics from simultaneous arerial and venous transcranial Doppler recordings in humans. Stoke22 (1991) 1148–1154.
2.
BecherHSchliefR.Improved sensitivity of colour Doppler by SH U 454. Am J Cardiol64 (1989) 374–377.
3.
BeckerGGreinerKKauneB.Diagnosis and monitoring of subarachnoid hemorrhage by transcranial colour-coded real-time sonography. Neurosurgery28 (1991) 814–820.
4.
BeckerGPerezJKroneADemuthKLindnerAHofmannEWinklerJBogdahnU.Transcranial colour-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. Neurosurgery31 (1992) 420–428.
5.
BeckerGBogdahnULindnerA.Imaging of the vertebro-basilas system by transcranial colour-coded real-time sonography. J Ultrasound Med12 (1993) 395–401.
6.
BeckerGBogdahnUGehlbergCFrihlichTHofmannESchliefR.Examination of intracerebral venous system by transcranial colour-coded real-time sonography: normal values of venous blood flow velocities and sonographic findings in cortical vein thrombosis. Stroke (submitted for publication) (1994).
BogdahnUBeckerGFröhlichTKroneASchliefRSchürmannJJachimczakPHofmannERoggendorfWRoosenK.Contrast-enhanced transcranial colour-coded realtime sonography allows detection of primary central nervous system tumour vascularisation. Radiology192 (1994) 141–148.
10.
FeinsteinSRCheirifJTen CateFJSilvermanPRHeidenreichPADickCDesirRMArmstrongWFQuinonesMAShoihPM. Safety and efficacy of a new transpulmonary ultrasound agent: initial multicenter clinical results. J Am Coll Cardiol16 (1990) 316–324.
11.
FritzschTHilmannJKämpfeMMüllerNSeiffertW.SHU 508 A, a transpulmonary stable contrast agent: initial experience. Invest Radiol25 (1990) 160–161.
12.
HennericiMRautenbergerWSchwartzA.Transcranial Doppler Ultrasound for the assessment of intracranial artery flow velocity - Evaluation of intracranial arterial disease. Surg Neurol27 (1987) 523–532.
13.
KapsMScidelGBauerTBehrmannB, Imaging of the intracranial vertebrobasilar system using colour-coded ultrasound. Stroke23 (1993) 1557–1582.
OphirJParkerKJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol15 (1989) 319–333.
16.
SchliefR.Diagnostic Potential of Intravenous Contrast Enhancement in Various Areas of Cardivascular Doppler Ultrasound: Efficacy Results of a Multinational Clinical Trial with the Galactose-Based Agent SH U 508 A. Endocardiography10 (1993) 665–682.
17.
SchöningMGrunertDStierB.Transkranielle real-time Sonography bei Kindern und Jugendlichen. Ultraschallanatomie des Gehirns. Ultraschall9 (1988) 286–292.
18.
SchöningMWalterJ.Evaluation of the vertebro-basilar-posterior system by transcranial colour Duplex sonography in adults. Stroke23 (1992) 1280–1286.
19.
SchöningMStaabMWalterJNiemannG.Transcranial colour duplex sonography in childhood and adolescence. Stroke24 (1993) 1305–1309.
20.
SchwartzKQBecharHSchimpfkyCVorwerkDBogdahnUSchliefRA. Study of the Magnitude of Doppler Enhancement with SH U 508 A in Multiple Vascular Regions. Radiology, in print, (1994).
21.
SmithMDElionJRMcLureRR. Lest heart opacification with peripheral venous injection of a new saccharride contrast agent in dogs. Am J Col Cardiol13 (1989) 1622–1628.
